Optimization of a Fast-track Concept for Knee Joint Replacement
- Conditions
- Postoperative ComplicationsKnee ArthropathyPostoperative Pain
- Registration Number
- NCT03920930
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
- In an estimated 150,000 patients, a knee joint replacement is performed in Germany every year. The perioperative care of the patients aims at an optimal surgical technique, which leads to a high functionality in the joint, and above all at an adequate pain treatment. Patients experience pain especially intraoperatively and in the first days after the operation. The intensity of pain is a decisive factor that can hinder the patient's mobilization. In the KneeOptOut study (ethics application number EA4/009/17), which has already been successfully carried out and approved by this ethics committee, it was shown that the use of local infiltration anaesthesia (LIA) for pain therapy after primary knee endoprosthetics is comparable to catheter-supported regional anaesthesia (manuscript under review at the European Journal of Anaesthesiology). During surgery, the morphine requirement of patients in the LIA group was significantly higher than that of patients who underwent catheterization. Postoperatively, however, both subjective pain by VAS and opiate consumption were comparable. 
 In order to optimize the intraoperative opiate need/consumption, an early-intraoperative procedure for local infiltration anesthesia will now be compared with the previous late-intraoperative procedure. Both procedures correspond to SOP for the treatment of primary knee endoprostheses and are currently used depending on the surgeon's requirements.
- Detailed Description
- Not available 
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
• patients undergoing elective, primary knee joint replacement in combined general anaesthesia
- heart insufficiency NYHA >2
- liver insufficiency > CHILD B
- evidence of diabetic polyneuropathy
- severe adipositas BMI >40
- patients < 18 years
- pregnancy
- in case of police custody
- participation in a paralleled interventional RCT in a time frame of 30 days
- chronic opioid therapy >3 months before scheduled surgery
- allergy against medication required for surgery or anaesthesia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
- Name - Time - Method - Opioid consumption - intraoperative, up to 3 hours - amount of opioids administered intraoperative measured as equivalent dose to morphin 
- Secondary Outcome Measures
- Name - Time - Method - time to first mobilisation (walking) - up to 7 days postoperatively - time from end of surgery until patients is able to walk - Opioid consumption (hospital) - up to 14 days postoperatively - amount of opioids administered until discharge measured as equivalent dose to morphin - patients satisfaction (11-point likert scale) - up to 7 days postoperatively - global satisfaction of patients - time to first mobilisation (standing) - up to 48 hours postoperatively - time from end of surgery until patients is able to stand - Janda grade of both legs at first day after surgery - up to 24h postoperatively - best Janda grade in both legs the day after surgery - Pain intensity - up to 7 days postoperatively - intensity of pain in all patients meausered by numeric rating scale (NRS) - time to discharge - up to 14 days postoperatively - time to discharge from hospital - surgeon satisfaction (6-point likert scale) - intraoperative, up to 3 hours - satisfaction of surgeon in points of clarity of the operative field, change of the operative field by LIA and overall satisfaction represented in one value - rescue pain medication - up to 7 days postoperatively - number of patients requiring rescue pain medication - delirium - up to 7 days postoperatively - incidence of postoperative delirium measured by Nursing Delirium Screening Scale (NuDeSc) - time to achieve full joint mobility - up to 7 days postoperatively - time to achieve full joint mobility (0/0/90°) - postoperative nausea and vomiting (PONV) - up to 7 days postoperatively - incidence of PONV 
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
- Charité - Universitätsmedizin Berlin 🇩🇪- Berlin, Germany Charité - Universitätsmedizin Berlin🇩🇪Berlin, Germany
